TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

Impact · against what's priced in

The P4 trial results provide a clinical validation catalyst for CT-guided PCI, demonstrating parity with IVUS outcomes and significant procedural efficiency. This expands the addressable market for HeartFlow's PCI Navigator by proving pre-procedural CCTA can replace or supplement gold-standard intra-procedural imaging.

Scored by the NIS engine · methodology.

TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

healthcare
cardiology
ccta

TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

What matters in this story

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

What matters in this story

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

Track these names every morning.

PolyNovo Limited (CALZF) Shareholder/Analyst Call Transcript

What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call

Moderna, Merck eye FDA approval for promising cancer vaccine

4 Blue-Chip Dividend Stocks That Kept Raising Payouts Through 2008 and 2020

TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

What matters in this story

Next reads from the same story arc

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients

What matters in this story

Next reads from the same story arc

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

Track these names every morning.

PolyNovo Limited (CALZF) Shareholder/Analyst Call Transcript

What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call

Moderna, Merck eye FDA approval for promising cancer vaccine

4 Blue-Chip Dividend Stocks That Kept Raising Payouts Through 2008 and 2020